Back to resultsPerceptions and Barriers About Cessation of Smoking Among IBD Patients
Primary Purpose
Smoking, Inflammatory Bowel Diseases
Status
Recruiting
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
smoking education
Sponsored by
About this trial
This is an interventional prevention trial for Smoking
Eligibility Criteria
Inclusion Criteria:
- Patients previously diagnosed with inflammatory bowel disease or newly diagnosed with inflammatory bowel disease
Exclusion Criteria:
- Those who do not agree to the survey or smoking cessation education
Sites / Locations
- KeimyungUniversityRecruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
smoking education
Arm Description
smoking education
Outcomes
Primary Outcome Measures
smoking cessation rate
Percentage of smokers who succeeded in quitting smoking
Secondary Outcome Measures
Full Information
NCT ID
NCT05182996
First Posted
December 21, 2021
Last Updated
December 21, 2021
Sponsor
Keimyung University Dongsan Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT05182996
Brief Title
Perceptions and Barriers About Cessation of Smoking Among IBD Patients
Official Title
Perceptions and Barriers About Cessation of Smoking Among IBD Patients
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Recruiting
Study Start Date
August 15, 2021 (Actual)
Primary Completion Date
March 31, 2022 (Anticipated)
Study Completion Date
October 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Keimyung University Dongsan Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will investigate the perception of the relationship between smoking and inflammatory bowel disease by surveying inflammatory bowel disease patients. Afterward, the relationship between smoking and inflammatory bowel disease will be explained, and the smoking cessation rate will be investigated three months later.
Detailed Description
A survey is conducted on patients with inflammatory bowel disease (IBD). Current smoking status, daily smoking amount, smoking period, perception of smoking effect on the induction of Crohn's disease (CD) or ulcerative colitis (UC), and perception of the effect of smoking on the course of CD or UC were investigated. Moreover, the intention to quit smoking is investigated. After the survey, information on the effects of smoking on CD or IBD is provided, and smoking cessation education is provided. After three months, the patients' smoking behavior was investigated, and the smoking cessation rate was investigated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Smoking, Inflammatory Bowel Diseases
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
350 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
smoking education
Arm Type
Other
Arm Description
smoking education
Intervention Type
Behavioral
Intervention Name(s)
smoking education
Intervention Description
Educate on the relationship between inflammatory bowel disease and smoking and the necessity and importance of quitting smoking.
Primary Outcome Measure Information:
Title
smoking cessation rate
Description
Percentage of smokers who succeeded in quitting smoking
Time Frame
3 month later
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients previously diagnosed with inflammatory bowel disease or newly diagnosed with inflammatory bowel disease
Exclusion Criteria:
Those who do not agree to the survey or smoking cessation education
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
YooJin Lee, professor
Phone
82-10-2755-0758
Email
doctorlyj@naver.com
Facility Information:
Facility Name
KeimyungUniversity
City
Daegu
State/Province
Jung-gu
ZIP/Postal Code
700-712
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yoo Jin Lee
Phone
+82-250-7088
Email
doctorlyj@naver.com
12. IPD Sharing Statement
Learn more about this trial
Perceptions and Barriers About Cessation of Smoking Among IBD Patients
We'll reach out to this number within 24 hrs